{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:43:47Z","timestamp":1793241827715,"version":"4.5.0"},"reference-count":97,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hematologic malignancies exhibit disparities in risk and outcomes across populations. A systematic review to identify prospective studies addressing disparities among patients with hematologic malignancies with an intervention or analysis at any level in the \u201cCells-to-Society\u201d model identified few studies and demonstrated literature gaps, which experts have supplemented with relevant citations. This review presents current research on diagnosis, treatment, and survival disparities and explores the roles of biology, cancer centers, community outreach, patient advocacy, and policies. Emphasis is placed on multilevel collaborative approaches to promote equity in healthcare delivery and improve survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This review underscores our shared responsibility to champion multidimensional strategies rooted in basic and translational science, community involvement, and societal responsiveness for a meaningful impact. Unifying themes include the need to enhance collaborative infrastructure to engage laboratory researchers, epidemiologists, data scientists, clinicians, patients, community leaders, and policymakers; patient-level support services; outreach, education, and navigation for patients at the community level; recruitment and retention of underrepresented groups in the healthcare and research workforce; and funding for these efforts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-24-0153","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:25:41Z","timestamp":1738574741000},"page":"79-93","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-3990","authenticated-orcid":false,"given":"Christopher R.","family":"Flowers","sequence":"first","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6831-9227","authenticated-orcid":false,"given":"Rachel W.","family":"Anantha","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5103-0684","authenticated-orcid":false,"given":"Veronica","family":"Leautaud","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-7284","authenticated-orcid":false,"given":"Pinkal","family":"Desai","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6982-7619","authenticated-orcid":false,"given":"Chancellor E.","family":"Donald","sequence":"additional","affiliation":[{"name":"3Section of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-6872","authenticated-orcid":false,"given":"Michelle A.T.","family":"Hildebrandt","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-0489","authenticated-orcid":false,"given":"Jean L.","family":"Koff","sequence":"additional","affiliation":[{"name":"4Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-8668","authenticated-orcid":false,"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3415-8247","authenticated-orcid":false,"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[{"name":"5Division of Hematology and Oncology, Department of Medicine, School of Medicine, University of California Irvine, Irvine, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9715-2577","authenticated-orcid":false,"given":"Chijioke","family":"Nze","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8074-2287","authenticated-orcid":false,"given":"Ari M.","family":"Melnick","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2026041309332320300_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026041309332320300_bib2","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"key":"2026041309332320300_bib3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2105\/AJPH.2006.102525","article-title":"Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities","volume":"98","author":"Warnecke","year":"2008","journal-title":"Am J Public Health"},{"key":"2026041309332320300_bib4","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2014-04-568766","article-title":"Socioeconomic disparities in lymphoma","volume":"123","author":"Flowers","year":"2014","journal-title":"Blood"},{"key":"2026041309332320300_bib5","first-page":"1","article-title":"Understanding and addressing disparities in patients with hematologic malignancies: approaches for clinicians","volume":"41","author":"Smith-Graziani","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026041309332320300_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cncr.23567","article-title":"The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study","volume":"113","author":"Byers","year":"2008","journal-title":"Cancer"},{"key":"2026041309332320300_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clml.2011.07.002","article-title":"Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States","volume":"11","author":"Shenoy","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026041309332320300_bib8","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"key":"2026041309332320300_bib9","first-page":"216","article-title":"Strategies for overcoming disparities for patients with hematologic malignancies and for improving enrollment on clinical trials","volume":"34","author":"Williams","year":"2020","journal-title":"Oncology (Williston Park)"},{"key":"2026041309332320300_bib10","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"2026041309332320300_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/10428194.2012.708751","article-title":"Examining racial differences in diffuse large B-cell lymphoma presentation and survival","volume":"54","author":"Flowers","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2026041309332320300_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"2026041309332320300_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41598-017-19081-4","article-title":"Racial differences in four leukemia subtypes: comprehensive descriptive epidemiology","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci Rep"},{"key":"2026041309332320300_bib14","volume-title":"Cells to society_ overcoming health disparities","author":"Center-for-Population-Health-and-Health-Disparities","year":"2007"},{"key":"2026041309332320300_bib15","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2105\/AJPH.2018.304730","article-title":"Designing and assessing multilevel interventions to improve minority health and reduce health disparities","volume":"109","author":"Agurs-Collins","year":"2019","journal-title":"Am J Public Health"},{"key":"2026041309332320300_bib16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026041309332320300_bib17","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J Club"},{"key":"2026041309332320300_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwaa215","article-title":"Trends in acute lymphoblastic leukemia incidence in the United States by race\/ethnicity from 2000 to 2016","volume":"190","author":"Feng","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2026041309332320300_bib19","doi-asserted-by":"crossref","first-page":"100526","DOI":"10.1016\/j.xgen.2024.100526","article-title":"A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic\/Latino children","volume":"4","author":"de Smith","year":"2024","journal-title":"Cell Genom"},{"key":"2026041309332320300_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood-2018-07-862946","article-title":"Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics","volume":"133","author":"Qian","year":"2019","journal-title":"Blood"},{"key":"2026041309332320300_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.23727","article-title":"Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia","volume":"89","author":"Walsh","year":"2014","journal-title":"Am J Hematol"},{"key":"2026041309332320300_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2011.38.0345","article-title":"ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia","volume":"30","author":"Xu","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026041309332320300_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ng.763","article-title":"Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia","volume":"43","author":"Yang","year":"2011","journal-title":"Nat Genet"},{"key":"2026041309332320300_bib24","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood.V128.22.1997.1997","article-title":"Racial disparities in patients with myelodysplastic syndrome (MDS): clinical and molecular depiction","volume":"128","author":"Ramadan","year":"2016","journal-title":"Blood"},{"key":"2026041309332320300_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.14061","article-title":"Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic\/myeloproliferative neoplasms in the United States, 2001\u201312","volume":"174","author":"Srour","year":"2016","journal-title":"Br J Haematol"},{"key":"2026041309332320300_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.leukres.2011.10.018","article-title":"Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience","volume":"36","author":"Bierenbaum","year":"2012","journal-title":"Leuk Res"},{"key":"2026041309332320300_bib27","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1182\/bloodadvances.2022007544","article-title":"High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML","volume":"6","author":"Larkin","year":"2022","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib28","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/s41588-024-01929-x","article-title":"Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia","volume":"56","author":"Stiff","year":"2024","journal-title":"Nat Genet"},{"key":"2026041309332320300_bib29","first-page":"705","article-title":"Impact of race on outcomes in intermediate-risk acute myeloid leukemia","volume":"32","author":"Abraham","year":"2021","journal-title":"Cancer Causes Control"},{"key":"2026041309332320300_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/2159-8290.CD-20-1579","article-title":"Poor survival and differential impact of genetic features of Black patients with acute myeloid leukemia","volume":"11","author":"Bhatnagar","year":"2021","journal-title":"Cancer Discov"},{"key":"2026041309332320300_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jha2.589","article-title":"Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia","volume":"3","author":"Bradley","year":"2022","journal-title":"EJHaem"},{"key":"2026041309332320300_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"2026041309332320300_bib33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","article-title":"Somatic mutations precede acute myeloid leukemia years before diagnosis","volume":"24","author":"Desai","year":"2018","journal-title":"Nat Med"},{"key":"2026041309332320300_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"key":"2026041309332320300_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1253\/circj.CJ-18-0871","article-title":"Clonal hematopoiesis and its impact on cardiovascular disease","volume":"83","author":"Sano","year":"2018","journal-title":"Circ J"},{"key":"2026041309332320300_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"key":"2026041309332320300_bib37","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-23-3468","article-title":"Plasma proteomic signature predicts myeloid neoplasm risk","volume":"30","author":"Tran","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026041309332320300_bib38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s43587-024-00647-7","article-title":"Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate","volume":"4","author":"Mack","year":"2024","journal-title":"Nat Aging"},{"key":"2026041309332320300_bib39","doi-asserted-by":"crossref","first-page":"e13366","DOI":"10.1111\/acel.13366","article-title":"Clonal hematopoiesis associated with epigenetic aging and clinical outcomes","volume":"20","author":"Nachun","year":"2021","journal-title":"Aging Cell"},{"key":"2026041309332320300_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","article-title":"Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling","volume":"11","author":"Lam","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2026041309332320300_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2026041309332320300_bib42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041309332320300_bib43","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/cncr.32866","article-title":"Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Lee","year":"2020","journal-title":"Cancer"},{"key":"2026041309332320300_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among Black and White women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"key":"2026041309332320300_bib45","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/s41467-018-04989-w","article-title":"Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma","volume":"9","author":"Went","year":"2018","journal-title":"Nat Commun"},{"key":"2026041309332320300_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ejh.12892","article-title":"Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)","volume":"99","author":"Thomsen","year":"2017","journal-title":"Eur J Haematol"},{"key":"2026041309332320300_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/bloodadvances.2019000491","article-title":"A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry","volume":"4","author":"Du","year":"2020","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-018-0132-1","article-title":"Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry","volume":"8","author":"Baughn","year":"2018","journal-title":"Blood Cancer J"},{"key":"2026041309332320300_bib49","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/bloodadvances.2021006652","article-title":"Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma","volume":"6","author":"Peres","year":"2022","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib50","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/2159-8290.CD-21-1514","article-title":"SETD2 haploinsufficiency enhances germinal center-associated AICDA somatic hypermutation to drive B-cell lymphomagenesis","volume":"12","author":"Leung","year":"2022","journal-title":"Cancer Discov"},{"key":"2026041309332320300_bib51","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acsmedchemlett.2c00167","article-title":"Conformational-design-driven discovery of EZM0414: a selective, potent SETD2 inhibitor for clinical studies","volume":"13","author":"Alford","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"2026041309332320300_bib52","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2017-03-775569","article-title":"SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia","volume":"130","author":"Mar","year":"2017","journal-title":"Blood"},{"issue":"Supp 2","key":"2026041309332320300_bib53","doi-asserted-by":"crossref","first-page":"P06","DOI":"10.1158\/2643-3249.BCDSYMP24-P06","article-title":"Abstract P06: characterization of the immune tumor microenvironment in a diverse cohort of patients with multiple myeloma","volume":"5","author":"Shivaram","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"2026041309332320300_bib54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/bloodadvances.2023010815","article-title":"Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups","volume":"8","author":"Shah","year":"2024","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41375-021-01132-5","article-title":"Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia","volume":"35","author":"Ge","year":"2021","journal-title":"Leukemia"},{"key":"2026041309332320300_bib56","doi-asserted-by":"crossref","first-page":"e0273735","DOI":"10.1371\/journal.pone.0273735","article-title":"Relative impact of genetic ancestry and neighborhood socioeconomic status on all-cause mortality in self-identified African Americans","volume":"17","author":"Iyer","year":"2022","journal-title":"PLoS One"},{"key":"2026041309332320300_bib57","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s11606-023-08051-4","article-title":"Modern day consequences of historic redlining: finding a path forward","volume":"38","author":"Egede","year":"2023","journal-title":"J Gen Intern Med"},{"key":"2026041309332320300_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MPH.0000000000002776","article-title":"Impact of social disparities on 5-year survival rates in pediatric hematologic malignancies","volume":"46","author":"Chalfant","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026041309332320300_bib59","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.jgo.2022.12.003","article-title":"Association of individual low-income status and area deprivation with mortality in multiple myeloma","volume":"14","author":"Hong","year":"2023","journal-title":"J Geriatr Oncol"},{"key":"2026041309332320300_bib60","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-018-0102-7","article-title":"Disease and outcome disparities in multiple myeloma: exploring the role of race\/ethnicity in the Cooperative Group Clinical Trials","volume":"8","author":"Ailawadhi","year":"2018","journal-title":"Blood Cancer J"},{"key":"2026041309332320300_bib62","doi-asserted-by":"crossref","first-page":"e7297","DOI":"10.1002\/cam4.7297","article-title":"\u201cThey don\u2019t care to study it\u201d: trust, race, and health care experiences among patient-caregiver dyads with multiple myeloma","volume":"13","author":"Grant","year":"2024","journal-title":"Cancer Med"},{"key":"2026041309332320300_bib63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/jayao.2021.0131","article-title":"Racial disparities in children, adolescents, and young adults with Hodgkin lymphoma enrolled in the New York State Medicaid Program","volume":"11","author":"Kahn","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2026041309332320300_bib64","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1002\/cncr.33868","article-title":"Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: a population-based study","volume":"127","author":"Kahn","year":"2021","journal-title":"Cancer"},{"key":"2026041309332320300_bib65","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/bloodadvances.2023011040","article-title":"Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL","volume":"8","author":"Nze","year":"2024","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib66","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.2021012830","article-title":"Structural racism is a mediator of disparities in acute myeloid leukemia outcomes","volume":"139","author":"Abraham","year":"2022","journal-title":"Blood"},{"key":"2026041309332320300_bib67","doi-asserted-by":"crossref","first-page":"107503","DOI":"10.1016\/j.leukres.2024.107503","article-title":"Racial and ethnic disparities in acute myeloid leukemia: 15-year experience at a safety net hospital system","volume":"141","author":"Dong","year":"2024","journal-title":"Leuk Res"},{"issue":"Suppl 1","key":"2026041309332320300_bib68","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2018-99-110649","article-title":"Cost of care at NCI-designated comprehensive cancer centers vs. other treatment sites for young adults with newly-diagnosed acute lymphoblastic leukemia (ALL)","volume":"132","author":"Wolfson","year":"2018","journal-title":"Blood"},{"key":"2026041309332320300_bib69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6004\/jnccn.2021.7048","article-title":"Improving health equity and reducing disparities in pediatric and adolescent\/young adult oncology: in support of clinical practice guidelines","volume":"19","author":"Kahn","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"2026041309332320300_bib70","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1182\/bloodadvances.2023010690","article-title":"Disparities in survival of hematologic malignancies in the context of social determinants of health: a systematic review","volume":"7","author":"Miranda-Galvis","year":"2023","journal-title":"Blood Adv"},{"key":"2026041309332320300_bib71","article-title":"Building trust, styling hair, saving lives","author":"University of Maryland School of Public Health"},{"key":"2026041309332320300_bib72","article-title":"The PROMISE study","author":"Dana Farber Cancer Institute"},{"key":"2026041309332320300_bib73","article-title":"Two grants aim to increase access to care and clinical trials for queens and brooklyn patients with blood cancers","author":"Weill Cornell Medicine Office of External Affairs"},{"key":"2026041309332320300_bib74","doi-asserted-by":"crossref","first-page":"21194","DOI":"10.1073\/pnas.1913405117","article-title":"Physician-patient racial concordance and disparities in birthing mortality for newborns","volume":"117","author":"Greenwood","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041309332320300_bib75","doi-asserted-by":"crossref","first-page":"e037099","DOI":"10.1002\/alz.037099","article-title":"Utilizing a mobile clinical trials unit: lessons learned from the first three years","volume":"16","author":"Smith","year":"2020","journal-title":"Alzheimer\u2019s Demen"},{"key":"2026041309332320300_bib76","doi-asserted-by":"crossref","first-page":"e221064","DOI":"10.1001\/jamahealthforum.2022.1064","article-title":"Addressing social determinants of health in federal programs","volume":"3","author":"De Lew","year":"2022","journal-title":"JAMA Health Forum"},{"key":"2026041309332320300_bib77","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1080\/16078454.2022.2141960","article-title":"Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [Grupo de Estudio de Linfoproliferativos de Latino Am\u00e9rica (GELL)]","volume":"27","author":"Villela","year":"2022","journal-title":"Hematology"},{"key":"2026041309332320300_bib78","first-page":"883","article-title":"Lessons to inform interventions to reduce racial and ethnic health disparities within hematologic malignancies","volume":"34","author":"Lin","year":"2023","journal-title":"Cancer Causes Control"},{"key":"2026041309332320300_bib79","doi-asserted-by":"crossref","first-page":"e432186","DOI":"10.1200\/EDBK_432186","article-title":"Hematopoietic stem-cell transplantation: exploring the latest advances and gaps in disparities, psychosocial and symptom management interventions, and chronic graft-versus-host disease care","volume":"44","author":"Trunk","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026041309332320300_bib80","doi-asserted-by":"crossref","first-page":"101169","DOI":"10.1016\/j.blre.2024.101169","article-title":"Disparity in hematological malignancies: from patients to health care professionals","volume":"65","author":"Chen","year":"2024","journal-title":"Blood Rev"},{"key":"2026041309332320300_bib81","doi-asserted-by":"crossref","first-page":"102082","DOI":"10.1016\/j.canep.2021.102082","article-title":"Demographic and socioeconomic disparities in pediatric cancer in the United States: current knowledge, deepening understanding, and expanding intervention","volume":"76","author":"Beltrami","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"2026041309332320300_bib82","first-page":"299","article-title":"An integrative review of sex differences in quality of life and symptoms among survivors of hematologic malignancies","volume":"50","author":"Tinsley-Vance","year":"2023","journal-title":"Oncol Nurs Forum"},{"key":"2026041309332320300_bib83","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12885-019-6093-3","article-title":"Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients","volume":"19","author":"Berger","year":"2019","journal-title":"BMC Cancer"},{"key":"2026041309332320300_bib84","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-18-0939","article-title":"Disparities in neurotoxicity risk and outcomes among pediatric acute lymphoblastic leukemia patients","volume":"24","author":"Taylor","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026041309332320300_bib85","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pbc.25510","article-title":"A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays","volume":"62","author":"Suarez","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2026041309332320300_bib86","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.18632\/oncotarget.3101","article-title":"Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans","volume":"6","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"key":"2026041309332320300_bib87","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s11136-012-0254-z","article-title":"Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma","volume":"22","author":"Kent","year":"2013","journal-title":"Qual Life Res"},{"key":"2026041309332320300_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"2026041309332320300_bib89","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2007.15.0169","article-title":"Individual physician practice variation in hematopoietic cell transplantation","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026041309332320300_bib90","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1186\/s12885-019-6478-3","article-title":"AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study","volume":"19","author":"Koffi","year":"2019","journal-title":"BMC Cancer"},{"key":"2026041309332320300_bib91","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12913-016-1553-9","article-title":"The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study","volume":"16","author":"Lamy","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"2026041309332320300_bib92","first-page":"41","article-title":"Delivering high-quality care to patients with a non-Hodgkin\u2019s lymphoma: barriers perceived by patients and physicians","volume":"72","author":"Stienen","year":"2014","journal-title":"Neth J Med"},{"key":"2026041309332320300_bib93","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1002\/cncr.27513","article-title":"Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study","volume":"118","author":"Nabhan","year":"2012","journal-title":"Cancer"},{"key":"2026041309332320300_bib94","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/bjc.2012.3","article-title":"Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark\u2013a Nationwide Study","volume":"106","author":"Frederiksen","year":"2012","journal-title":"Br J Cancer"},{"key":"2026041309332320300_bib95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/1117-1936.180914","article-title":"The effect of accessibility to drugs on outcome of therapy in patients with malignant lymphoma","volume":"15","author":"Emoti","year":"2008","journal-title":"Niger Postgrad Med J"},{"key":"2026041309332320300_bib96","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1038\/s41467-023-41223-8","article-title":"Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study","volume":"14","author":"Huber","year":"2023","journal-title":"Nat Commun"},{"key":"2026041309332320300_bib97","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hon.2422","article-title":"Age-related health care disparities in multiple myeloma","volume":"36","author":"Puyade","year":"2018","journal-title":"Hematol Oncol"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-24-0153\/3538619\/bcd-24-0153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/2\/79\/3545825\/bcd-24-0153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/2\/79\/3545825\/bcd-24-0153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:33:37Z","timestamp":1776087217000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/6\/2\/79\/752036\/Addressing-Health-Disparities-in-Hematologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-24-0153","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.28531527","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.28531530","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7702674","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}